Search for a report

ASIA PACIFIC BIOCHIPS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Downloads
  • ASIA PACIFIC BIOCHIPS MARKET FORECAST 2019-2028

ASIA PACIFIC BIOCHIPS MARKET FORECAST 2019-2028

The Asia Pacific biochips market is anticipated to record remarkable growth at a CAGR of 14.06% during the forecast period of 2019-2028. Some of the major factors boosting the Asia Pacific biochips market are an increase in demand for drug discovery, a rise in the utilization of personalized medicines, an upsurge in demand for high-speed diagnostics, and ongoing R&D and innovation related to biochips and genomic.

ASIA PACIFIC BIOCHIPS MARKET FORECAST 2019-2028

Asia Pacific Biochips Market by Type (DNA Chips, Lab on a Chip, Protein Chips & Other Chips)  by Substrate Materials (Glass, Polymers, Silicon & Other Substrate Materials)  by End Users (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic and Research Institute) by Geography

Request free sample

The Asia Pacific biochips market is anticipated to record remarkable growth at a CAGR of 14.06% during the forecast period of 2019-2028. Some of the major factors boosting the Asia Pacific biochips market are an increase in demand for drug discovery, a rise in the utilization of personalized medicines, an upsurge in demand for high-speed diagnostics, and ongoing R&D and innovation related to biochips and genomic.
Asia Pacific Biochips Market

To know more about this report, request a free sample copy.

In order to analyze the Asia Pacific biochips market, the region is segmented into India, Vietnam, Australia & New Zealand, Thailand, Indonesia, Japan, South Korea, China, and the rest of Asia Pacific. In China, the presence of a huge number of global companies with R&D units, along with the regulatory framework, is encouraging new and advanced clinical research techniques. China is also leading in the technology of lab-on-a–chip-based POC. Hence, the growing focus on clinical research, technological developments, precision medicine, and new drug discovery are the driving factors for regional market growth. Japanese researchers have been making huge contributions to biochip technology for a long time. The implementation of ‘body-on-chip’ was developed by Kyoto University. The Japanese market growth is supported by continuous research, public and private sectors, and the presence of market players.

In India, an increasing number of researches have propelled the demand for LOC models, helping the overall market growth. The use of microarray chips in viral diagnosis in Indian livestock has increased recently. The biochip startups and the increasing research on lab on a chip technology are fueling the market growth. In countries like South Korea, biochip technology is used for drug discovery. The surging research and funding by the government and private organizations will drive market growth.

F. Hoffmann-La Roche develops and markets innovative diagnostic and therapeutic products. The company operates in North America, Europe, Australia, Latin America, Africa, Asia, and Oceania. In Jan 2020, the company partnered with Illumina to expand the adoption of distributable NGS testing in oncology.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
      • DEVELOPMENT OF BIOCHIPS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • RISING INCIDENCES OF CHRONIC DISEASES
        • GROWING INTEREST IN PERSONALIZED MEDICINES
        • APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
        • RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
      •    KEY RESTRAINTS
        • HIGH INSTRUMENTATION COST
        • LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
        • AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
        • COMPLEXITY OF BIOLOGICAL SYSTEMS
        • LACK OF COMMON REGULATORY STANDARDS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON BIOCHIPS
      • KEY INVESTMENT INSIGHTS
      •    PORTER’S FIVE FORCE ANALYSIS
        • BUYER POWER
        • SUPPLIER POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      •    VALUE CHAIN ANALYSIS
        • RESEARCH & DEVELOPMENT
        • RAW MATERIALS
        • MANUFACTURING
        • WHOLESALERS/RETAILERS/DISTRIBUTORS
        • END-USER
      •    KEY BUYING CRITERIA
        • COST
        • APPLICATIONS
        • PRODUCT TYPE
      • REGULATORY FRAMEWORK
    2. MARKET BY TYPE
      •    DNA CHIPS
        • AGRICULTURAL BIOTECHNOLOGY
        • CANCER DIAGNOSIS & TREATMENT
        • DRUG DISCOVERY
        • GENE EXPRESSION
        • GENOMICS
        • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
        • OTHER DNA CHIPS
      •    LAB ON A CHIP
        • CLINICAL DIAGNOSTICS
        • DRUG DISCOVERY
        • GENOMICS
        • POINT OF CARE & IN VITRO DIAGNOSIS
        • PROTEOMICS
        • OTHER LAB ON A CHIP
      •    PROTEIN CHIPS
        • DIAGNOSTICS
        • DRUG DISCOVERY
        • EXPRESSION PROFILING
        • HIGH THROUGHPUT SCREENING
        • PROTEOMICS
        • OTHER PROTEIN CHIPS
      •    OTHER TYPES
        • CELL ARRAYS
        • TISSUE ARRAYS
    1. MARKET BY SUBSTRATE MATERIALS
      • GLASS
      • POLYMERS
      • SILICON
      • OTHER SUBSTRATE MATERIALS
    2. MARKET BY END-USER
      • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
      • HOSPITALS AND DIAGNOSTICS CENTERS
      • ACADEMIC AND RESEARCH INSTITUTES
    3. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA PACIFIC
    1. COMPANY PROFILES
      • ABBOTT LABORATORIES INC
      • AGILENT TECHNOLOGIES INC
      • BIOCHAIN INSTITUTE INC
      • BIOMÉRIEUX SA
      • BIO-RAD LABORATORIES INC
      • CEPHEID
      • CYBRDI INC
      • F HOFFMANN-LA ROCHE LTD
      • FLUIDIGM CORPORATION
      • GE HEALTHCARE
      • ILLUMINA INC
      • MERCK KGAA
      • PERKINELMER INC
      • RANDOX LABORATORIES LTD
      • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – BIOCHIPS

    TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018

    TABLE 3: REGULATORY FRAMEWORK

    TABLE 4: ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 7: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 8: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 9: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 10: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 11: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 12: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 13: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 14: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS

    TABLE 15: ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 16: ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 17: ASIA PACIFIC BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 18: ASIA PACIFIC BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 19: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 20: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    LIST OF FIGURES

    FIGURE 1: DEVELOPMENT OF BIOCHIPS

    FIGURE 2: KEY INVESTMENT INSIGHTS

    FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: VALUE CHAIN ANALYSIS

    FIGURE 7: KEY BUYING CRITERIA

    FIGURE 8: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019

    FIGURE 9: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 10: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019

    FIGURE 11: ASIA PACIFIC BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)

    FIGURE 12: ASIA PACIFIC BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)

    FIGURE 13: ASIA PACIFIC BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 14: ASIA PACIFIC BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 15: ASIA PACIFIC BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 16: ASIA PACIFIC BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)

    FIGURE 17: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 18: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)

    FIGURE 19: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019

    FIGURE 20: ASIA PACIFIC BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)

    FIGURE 21: ASIA PACIFIC BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 22: ASIA PACIFIC BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 23: ASIA PACIFIC BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)

    FIGURE 24: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 25: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)

    FIGURE 26: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 27: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019

    FIGURE 28: ASIA PACIFIC BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)

    FIGURE 29: ASIA PACIFIC BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 30: ASIA PACIFIC BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)

    FIGURE 31: ASIA PACIFIC BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)

    FIGURE 32: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 33: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 34: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)

    FIGURE 35: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019

    FIGURE 36: ASIA PACIFIC BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)

    FIGURE 37: ASIA PACIFIC BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)

    FIGURE 38: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019

    FIGURE 39: ASIA PACIFIC BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)

    FIGURE 40: ASIA PACIFIC BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)

    FIGURE 41: ASIA PACIFIC BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)

    FIGURE 42: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)

    FIGURE 43: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019

    FIGURE 44: ASIA PACIFIC BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)

    FIGURE 45: ASIA PACIFIC BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)

    FIGURE 46: ASIA PACIFIC BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)

    FIGURE 47: ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

    FIGURE 48: CHINA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 49: JAPAN BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 50: INDIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 51: SOUTH KOREA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 52: INDONESIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 53: THAILAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 54: VIETNAM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 55: AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 56: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA PACIFIC
    1. MARKET BY TYPE
      •    DNA CHIPS
        • AGRICULTURAL BIOTECHNOLOGY
        • CANCER DIAGNOSIS & TREATMENT
        • DRUG DISCOVERY
        • GENE EXPRESSION
        • GENOMICS
        • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
        • OTHER DNA CHIPS
      •    LAB ON A CHIP
        • CLINICAL DIAGNOSTICS
        • DRUG DISCOVERY
        • GENOMICS
        • POINT OF CARE & IN VITRO DIAGNOSIS
        • PROTEOMICS
        • OTHER LAB ON A CHIP
      •    PROTEIN CHIPS
        • DIAGNOSTICS
        • DRUG DISCOVERY
        • EXPRESSION PROFILING
        • HIGH THROUGHPUT SCREENING
        • PROTEOMICS
        • OTHER PROTEIN CHIPS
      •    OTHER TYPES
        • CELL ARRAYS
        • TISSUE ARRAYS
    1. MARKET BY SUBSTRATE MATERIALS
      • GLASS
      • POLYMERS
      • SILICON
      • OTHER SUBSTRATE MATERIALS
    2. MARKET BY END-USER
      • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
      • HOSPITALS AND DIAGNOSTICS CENTERS
      • ACADEMIC AND RESEARCH INSTITUTES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now